31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age

Main Article Content

Christine Bailey
Castle Biosciences, Inc., Friendswood, TX

Brian Martin
Castle Biosciences, Inc., Friendswood, TX

Valentina Petkov
National Cancer Institute

Jennifer Siegel
Castle Biosciences, Inc., Friendswood, TX

Sarah Kurley
Castle Biosciences, Inc., Friendswood, TX

Kyle Covington
Castle Biosciences, Inc., Friendswood, TX

Keywords

Skin cancer

Abstract

N/A

References

1. Hsueh et al. JCO PO 2021.

2. Arnot et al. AJS. 2021.

3. Gastman et al. JAAD. 2019. Greenhaw et al. JAAD. 2019.

4. Keller et al. Cancer Med. 2019. Podlipnik et al. JEADV. 2019.

5. Jarell et al. Fut Onc. 2021. 8. Vetto et al. Fut Onc.
2019.

6. Dillon et al. SKIN J Cutan Med. 2018. 10. Berger et al. Cur Med Res and Opinion. 2016.
11. Farberg et al.
JDD. 2017.

7. Schuitevoerder et al. JDD. 2018. 13. Svoboda et al. JDD. 2018. 14. Marson et al. SKIN J Cutan Med.
2021.

8. Kwatra et al. JCAD 2020. 16. Morton et al. NEJM. 2014.

Article Sidebar

Poster PDF
Published
Mar 4, 2022
DOI https://doi.org/10.25251/skin.6.supp.24

Article Details

How to Cite
[1]
Bailey, C. , Martin, B., Petkov, V., Siegel, J., Kurley, S. and Covington, K. 2022. 31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age. SKIN The Journal of Cutaneous Medicine. 6, 2 (Mar. 2022), s24. DOI:https://doi.org/10.25251/skin.6.supp.24.
Issue
Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®)
Section
Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.